UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 348

Sortiert nach

Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study

The lancet oncology, 2015-12, Vol.16 (16), p.1667-1676

2015

Link zum Volltext

Verfügbarkeit prüfen

Long-term treatment patterns and survival in metastatic breast cancer by intrinsic subtypes – an observational cohort study in Sweden

BMC cancer, 2022-09, Vol.22 (1), p.1-1006, Article 1006

2022

Link zum Volltext

Verfügbarkeit prüfen

Oral corticosteroid use, morbidity and mortality in asthma: A nationwide prospective cohort study in Sweden

Allergy (Copenhagen), 2019-11, Vol.74 (11), p.2181-2190

2019

Link zum Volltext

Verfügbarkeit prüfen

FACT: An Open-Label Randomized Phase III Study of Fulvestrant and Anastrozole in Combination Compared With Anastrozole Alone As First-Line Therapy for Patients With Receptor-Positive Postmenopausal Breast Cancer

Journal of clinical oncology, 2012-06, Vol.30 (16), p.1919-1925

2012

Link zum Volltext

Verfügbarkeit prüfen

Macrophage inhibitory cytokine‐1 (MIC‐1/GDF15): a new marker of all‐cause mortality

Aging cell, 2010-12, Vol.9 (6), p.1057-1064

2010

Link zum Volltext

Verfügbarkeit prüfen

Macrophage Inhibitory Cytokine 1: A New Prognostic Marker in Prostate Cancer

Clinical cancer research, 2009-11, Vol.15 (21), p.6658-6664

2009

Link zum Volltext

Verfügbarkeit prüfen

Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial

The Lancet (British edition), 2009, Vol.373 (9660), p.301-308

2009

Link zum Volltext

Verfügbarkeit prüfen

The Mitochondrial and Autosomal Mutation Landscapes of Prostate Cancer

European urology, 2013-04, Vol.63 (4), p.702-708

2013

Link zum Volltext

Verfügbarkeit prüfen

Gene regulatory mechanisms underpinning prostate cancer susceptibility

Nature genetics, 2016-04, Vol.48 (4), p.387-397

2016

Link zum Volltext

Verfügbarkeit prüfen

A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding

Nature genetics, 2014-02, Vol.46 (2), p.126-135

2014

Link zum Volltext

Verfügbarkeit prüfen

Histopathological features of ductal adenocarcinoma of the prostate in 1,051 radical prostatectomy specimens

Virchows Archiv : an international journal of pathology, 2013-04, Vol.462 (4), p.429-436

2013

Link zum Volltext

Verfügbarkeit prüfen

Polygenic Risk Score Improves Prostate Cancer Risk Prediction: Results from the Stockholm-1 Cohort Study

European urology, 2011-07, Vol.60 (1), p.21-28

2011

Link zum Volltext

Verfügbarkeit prüfen

Synergistic Interaction of HOXB13 and CIP2A Predisposes to Aggressive Prostate Cancer

Clinical cancer research, 2018-12, Vol.24 (24), p.6265-6276

2018

Link zum Volltext

Verfügbarkeit prüfen

A Missense Mutation in the Aggrecan C-type Lectin Domain Disrupts Extracellular Matrix Interactions and Causes Dominant Familial Osteochondritis Dissecans

American journal of human genetics, 2010-02, Vol.86 (2), p.126-137

2010

Link zum Volltext

Verfügbarkeit prüfen

High use of short-acting β2-agonists in COPD is associated with an increased risk of exacerbations and mortality

ERJ open research, 2023-05, Vol.9 (3)

2023

Link zum Volltext

Verfügbarkeit prüfen

Interaction between Single Nucleotide Polymorphisms in Selenoprotein P and Mitochondrial Superoxide Dismutase Determines Prostate Cancer Risk

Cancer research (Chicago, Ill.), 2008-12, Vol.68 (24), p.10171-10177

2008

Link zum Volltext

Verfügbarkeit prüfen

Inherited DNA Repair Gene Mutations in Men with Lethal Prostate Cancer

Genes, 2020-03, Vol.11 (3), p.314

2020

Link zum Volltext

Verfügbarkeit prüfen

Immunohistochemical profile of ductal adenocarcinoma of the prostate

Virchows Archiv : an international journal of pathology, 2014-11, Vol.465 (5), p.559-565

2014

Link zum Volltext

Verfügbarkeit prüfen

Is genetic background important in lung cancer survival?

PloS one, 2009-05, Vol.4 (5), p.e5588-e5588

2009

Link zum Volltext

Verfügbarkeit prüfen

Prospective Seroepidemiologic Study of Human Papillomavirus and Other Risk Factors in Cervical Cancer

Cancer epidemiology, biomarkers & prevention, 2011-12, Vol.20 (12), p.2541-2550

2011

Link zum Volltext

Verfügbarkeit prüfen

Inherited genetic variant predisposes to aggressive but not indolent prostate cancer

Proceedings of the National Academy of Sciences - PNAS, 2010-02, Vol.107 (5), p.2136-2140

2010

Link zum Volltext

Verfügbarkeit prüfen

Genetic Variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF Genes Are Prognostic Markers of Prostate Cancer-Specific Mortality

Cancer epidemiology, biomarkers & prevention, 2011-09, Vol.20 (9), p.1928-1936

2011

Link zum Volltext

Verfügbarkeit prüfen

Estimating Heritability of Prostate Cancer‐Specific Survival Using Population‐Based Registers

The Prostate, 2017-06, Vol.77 (8), p.900-907

2017

Link zum Volltext

Verfügbarkeit prüfen

Overuse of short-acting beta(2)-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme

The European respiratory journal, 2020-04, Vol.55 (4)

2020

Link zum Volltext

Verfügbarkeit prüfen

Quality of life in patients with locally advanced prostate cancer given endocrine treatment with or without radiotherapy: 4-year follow-up of SPCG-7/SFUO-3, an open-label, randomised, phase III trial

The lancet oncology, 2009-04, Vol.10 (4), p.370-380

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 348

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(333)
Mit Volltextzugriff
(336)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study

Long-term treatment patterns and survival in metastatic breast cancer by intrinsic subtypes – an observational cohort study in Sweden

Oral corticosteroid use, morbidity and mortality in asthma: A nationwide prospective cohort study in Sweden

FACT: An Open-Label Randomized Phase III Study of Fulvestrant and Anastrozole in Combination Compared With Anastrozole Alone As First-Line Therapy for Patients With Receptor-Positive Postmenopausal Breast Cancer

Macrophage inhibitory cytokine‐1 (MIC‐1/GDF15): a new marker of all‐cause mortality

Macrophage Inhibitory Cytokine 1: A New Prognostic Marker in Prostate Cancer

Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial

The Mitochondrial and Autosomal Mutation Landscapes of Prostate Cancer

Gene regulatory mechanisms underpinning prostate cancer susceptibility

A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding

Histopathological features of ductal adenocarcinoma of the prostate in 1,051 radical prostatectomy specimens

Polygenic Risk Score Improves Prostate Cancer Risk Prediction: Results from the Stockholm-1 Cohort Study

Synergistic Interaction of HOXB13 and CIP2A Predisposes to Aggressive Prostate Cancer

A Missense Mutation in the Aggrecan C-type Lectin Domain Disrupts Extracellular Matrix Interactions and Causes Dominant Familial Osteochondritis Dissecans

High use of short-acting β2-agonists in COPD is associated with an increased risk of exacerbations and mortality

Interaction between Single Nucleotide Polymorphisms in Selenoprotein P and Mitochondrial Superoxide Dismutase Determines Prostate Cancer Risk

Inherited DNA Repair Gene Mutations in Men with Lethal Prostate Cancer

Immunohistochemical profile of ductal adenocarcinoma of the prostate

Is genetic background important in lung cancer survival?

Prospective Seroepidemiologic Study of Human Papillomavirus and Other Risk Factors in Cervical Cancer

Inherited genetic variant predisposes to aggressive but not indolent prostate cancer

Genetic Variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF Genes Are Prognostic Markers of Prostate Cancer-Specific Mortality

Estimating Heritability of Prostate Cancer‐Specific Survival Using Population‐Based Registers

Overuse of short-acting beta(2)-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme

Quality of life in patients with locally advanced prostate cancer given endocrine treatment with or without radiotherapy: 4-year follow-up of SPCG-7/SFUO-3, an open-label, randomised, phase III trial

Suchergebnisse filtern